Categories: News

CSS Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

BUFFALO, N.Y., Jan. 25, 2022 /PRNewswire/ — CSS Health, a leading provider of Medication Therapy Management Software and Services, today announced it’s Payer Services unit (formerly CSS) has earned Certified status for information security by HITRUST.

CSS Health Achieves HITRUST CSF® Certification to Further Mitigate Risk in Third-Party Privacy, Security, and Compliance

HITRUST CSF Certified status demonstrates that the organization’s CSS Health has met key regulations and industry-defined requirements and is appropriately managing risk. This achievement places CSS Health in an elite group of organizations worldwide that have earned this certification. By including federal and state regulations, standards, and frameworks, and incorporating a risk-based approach, the HITRUST CSF helps organizations address these challenges through a comprehensive and flexible framework of prescriptive and scalable security controls.

“Technology-enabled Pharmacy Services companies, like ours, are under more pressure than ever to meet complex compliance and privacy requirements that include technical and process elements such as NIST, ISO, and COBIT,” said James A. Clair , CEO  at CSS Health. “We are pleased to demonstrate to our customers the highest standards for protecting sensitive data and information by achieving HITRUST CSF Certification.”

“In today’s ever-changing threat landscape, HITRUST is continually innovating to find new and creative approaches to address challenges,” said Jeremy Huval, Chief Innovation Officer, HITRUST. “CSS Health’s HITRUST CSF Certification is evidence that they are at the forefront of industry best practices for information risk management and compliance.”

About  CSS Health
CSS Health provides a comprehensive Medication Therapy Management (MTM), adherence and compliance drug packaging solution for health plans, pharmacy benefit managers (PBMs), pharmacies, facilities, and patients. Our dedicated leadership team has deep and broad experience in payer and pharmacy services. CSS Health brings together Clinical Support Services, a leader in MTM clinical software and services, and Medicine-On-Time, an innovator in multi-dose and single dose compliance packaging and prescription management software for more than 30 years, in an end-to-end medication management solution. For more information about CSS Health, please visit www.csshealth.com

CSS Health Media Contact:                                                   
Miklos Van Halen, CTO
CSS Health
mvanhalen@csshealth.com              

                               

View original content to download multimedia:https://www.prnewswire.com/news-releases/css-health-achieves-hitrust-csf-certification-to-further-mitigate-risk-in-third-party-privacy-security-and-compliance-301467803.html

SOURCE CSS Health

Staff

Recent Posts

NervGen Pharma Announces Proposed Amendment to Warrants

Vancouver, British Columbia--(Newsfile Corp. - December 12, 2025) - NervGen Pharma Corp. (TSXV: NGEN) (OTCQB:…

2 hours ago

MyndTec Inc. Completes Ninth Tranche of Non-Brokered Private Placement

Mississauga, Ontario--(Newsfile Corp. - December 12, 2025) - MyndTec Inc. (CSE: MYTC) ("MyndTec" or the "Company"),…

4 hours ago

Dominari Holdings Announces Change of Record Date and Payment Date for $10 Million Cash Dividend

NEW YORK, Dec. 12, 2025 /PRNewswire/ -- Dominari Holdings Inc. (Nasdaq: DOMH) is pleased to announce…

4 hours ago

ISHI Health Launches Virtual Heart Failure Clinics in California and Arizona

SAN DIEGO, Dec. 12, 2025 /PRNewswire/ -- ISHI Health, an innovator in AI-enabled virtual cardiac…

4 hours ago

Zealthy Review 2026: How Zealthy Compares to FitRx and RoenRx for Weight Loss & GLP-1 Care

LOS ANGELES, CA / ACCESS Newswire / December 12, 2025 / The landscape of weight…

4 hours ago

Aspire Biopharma Granted Extension by Nasdaq Hearing Panel to Regain Compliance with Continued Listing Requirements

ESTERO, FL / ACCESS Newswire / December 12, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP)…

4 hours ago